Effect of compound rhodiola sachalinensis A Bor on CCl4-induced liver fibrosis in rats and its probable molecular mechanisms

World Journal of Gastroenterology

Volumn 9, Issue 7, 2003, Pages 1559-1562

  Wu, Xiao Ling ^b   Zeng, Wei Zheng ^a   Wang, Pi Long ^b   Lei, Chun Tao ^b   Jiang, Ming De ^a   Chen, Xiao Bin ^a   Zhang, Yong ^a   Xu, Hui ^a   Wang, Zhao ^a  

^a CHENGDU MILITARY GENERAL HOSPITAL   (China)

^b CHONGQING MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ALPHA1(I) MESSENGER RNA; ASPARTATE AMINOTRANSFERASE; CARBON TETRACHLORIDE; CHINESE DRUG; COLLAGEN TYPE 4; DYE; EOSIN; HEMATOXYLIN; HYALURONIC ACID; MESSENGER RNA; N ACETYL BETA GLUCOSAMINIDASE; PROCOLLAGEN; PROCOLLAGEN TYPE 3; RHODIOLA SACHALINENSIS A BOR; SODIUM CALCIUM EXCHANGE PROTEIN; TRANSFORMING GROWTH FACTOR BETA1; UNCLASSIFIED DRUG;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CELL ACTIVATION; CHINESE MEDICINE; COLLAGEN SYNTHESIS; CONTROLLED STUDY; DRUG DOSE REGIMEN; DRUG MECHANISM; ENZYME ACTIVITY; ENZYME BLOOD LEVEL; ENZYME INHIBITION; HISTOPATHOLOGY; IN SITU HYBRIDIZATION; LIVER FIBROSIS; MALE; NONHUMAN; PROTEIN BLOOD LEVEL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN SYNTHESIS INHIBITION; RANDOMIZATION; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STAINING; STELLATE CELL;

EID: 0041563743     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.v9.i7.1559     Document Type: Article

References (33)

1. Bissell DM, Roulot D, George J. Transforming growth factor β and the liver. Hepatology 2001; 34: 859-867
2. Liu F, Liu JX. The role of transforming growth factor b1 in liver fibrosis. Shijie Huaren Xiaohua Zazhi 2000; 8: 86-88
3. Schuppan D, Porov Y. Hepatic fibrosis: From bench to bedside. J Gastroenterol Hepatol 2002; 7(Suppl 3):S300-S305
4. Cui DL, Yao XX. The serum detection of liver fibrosis. Shijie Huaren Xiaohua Zazhi 2000; 8: 683-684
5. Qin JP, Jiang MD. The phenotype and regulation of hepatic stellate cell and liver fibrosis. Shijie Huaren Xiaohua Zazhi 2001; 9: 801-804
6. Wu JX, Meng XJ, Chen YW, Li DG, Lu HM. Message molecular of Smads and the activation of hepatic stellate cells. Weichangbingxue He Ganbingxue Zazhi 2002; 11: 197-199
7. Shi YJ, Tian ZB, Zhao QX. The current research of Smads protein family. Zhonghua Fubu Jibing Zazhi 2002; 2: 497-500
8. Li D, Friedman SL. Liver fibrogenesis and the role of hepatic stellate cells: New insights and prospects for therapy. J Gastroenterol Hepatol 1999; 14: 618-633
9. George J, Roulot D, Kotelinnsky VE, Bissell DM. In vivo inhibition of rat stellate cell activation by soluble transforming growth factor β type II receptor: A potential new therapy for hepatic fibrosis. Proc Natl Acad Sci USA 1999; 96: 12719-12724
10. Yoshiji H, Kuriyama S, Yoshii J, Ikenaka Y, Noguchi R, Nakatani T, Tsujinoue H, Fukui H. Angiotensin-II type 1 receptor interaction is a major regulator for liver fibrosis development in rats. Hepatology 2001; 34(4Pt 1): 745-750
11. Jiang SL, Yao XX, Sun YF. The treatment of liver fibrosis. Shijie Huaren Xiaohua Zazhi 2000; 8: 684-686
12. Sun YF, Yao XX, Jiang SL. The traditional Chinese medicine treatment of liver fibrosis. Shijie Huaren Xiaohua Zazhi 2000; 8: 686-687
13. Du WD, Zhang YE, Zhai WR, Zhou XM. Dynamic changes of type I, III and IV collagen synthesis and distribution of collagen-producing cells in carbon tetrachloride-induced rat liver fibrosis. World J Gastroenterol 1999; 5: 397-403
14. Liu P, Liu C, Xu LM, Xue HM, Liu CH, Zhang ZQ. Effects of Fuzheng Huayu 319 recipe on liver fibrosis in chronic hepatitis B. World J Gastroenterol 1998; 4: 348-353
15. Liu CH, Hu YY, Wang XL, Liu P, Xu LM. Effects of salvianolic acid-A on NIH/3T3 fibroblast proliferation, collagen synthesis and gene expression. World J Gastroenterol 2000; 6: 361-364
16. Cai DY, Zhao G, Chen JC, Ye GM, Bing FH, Fan BW. Therapeutic effect of Zijin capsule in liver fibrosis in rats. World J Gastroenterol 1998; 4: 260-263
17. Shimizu I. Sho-saiko-to:Japanese herbal medicine for protection against hepatic fibrosis and carcinoma. J Gastroenterol Hepatol 2000; 15(Suppl):d84-90
18. Yang W, Zeng M, Fan Z, Mao Y, Song Y, Jia Y, Lu L, Chen CW, Peng YS, Zhu HY. Prophylactic and therapeutic effect of oxymatrine on D-galactosamine-induced rat liver fibrosis. Zhonghua Ganzanging Zazhi 2002; 10: 193-196
19. 4-induced liver fibrosis in rats. Am J Chin Med 1998; 16: 325-332
20. Liu P, Hu YY, Liu C, Zhu DY, Xue HM, Xu ZQ, Xu LM, Liu CH, Gu HT, Zhang ZQ. Clinical observation of salvianolic acid B in treatment of liver fibrosis in chronic hepatitis B. World J Gastroenterol 2002; 8: 679-685
21. 4-induced liver fibrosis. Zhongguo Zhongxiyi Jiehe Xiaohua Zazhi 2002; 10: 138-141
22. Jiang MD, Gan XY, Xie FW, Zeng WZ, Wu XL. Effect of salidroside on the proliferation and collagen mRNA transcription in rat hepatic stellate cells stimulated by acetaldehyde. Yaoxue Xuebao 2002; 37: 841-844
23. 4-induced liver fibrosis. Huaxi Yaoxue Zazhi 2002; 17: 416-418
24. Schuppan D, Koda M, Bauer M, Hahn EG. Fibrosis of liver, pancreas and intestine: Common mechanisms and clear targets? Acta Gastroenterol Belg 2000; 63: 366-370
25. Gressner AM, Weiskirchen R, Breitkopf K, Dooley S. Roles of TGF-beta in hepatic fibrosis. Front Biosci 2002; 7: d793-807
26. Neuman MG, Benhamou JP, Bourliere M, Ibrahim A, Malkiewicz I, Asselah T, Martinot-Peignoux M, Shear NH, Katz GG, Akremi R, Benali S, Boyer N, Lecomte L, Le Breton V, Le Guludec G, Marcellin P. Serum tumour necrosis factor-alpha and transforming growth factor-beta levels in chronic hepatitis C patients are immunomodulated by therapy. Cytokine 2002; 17: 108-117
27. Bissell DM. Chronic liver injury, TGF-beta, and cancer. Exp Mol Med 2001; 33: 179-190
28. Kanzler S, Baumann M, Schirmacher P, Dries V, Bayer E, Gerken G, Dienes HP, Lohse AW. Prediction of progressive liver fibrosis in hepatitis C infection by serum and tissue levels of transforming growth factor-beta. J Viral Hepat 2001; 8: 430-437
29. Paizis G, Gilbert RE, Cooper ME, Murthi P, Schembri JM, Wu LL, Rumble JR, Kelly DJ, Tikellis C, Cox A, Smallwood RA, Angus PW. Effect of angiotensin II type 1 receptor blockade on experimental hepatic fibrogenesis. J Hepatol 2001; 35: 376-385
30. Deng L, Zhou Y, Peng X, Deng H, Deng Y, Yao J. Serum markers and pathological evaluation in hepatitis fibrosis of chronic hepatitis B treated with interferon alpha. Zhonghua Ganzangbing Zazhi 2001; 9: 66-67
31. Jiang W, Wang J, Yang C, Wang Y, Liu W, He B. Effects of antisensen transforming growth factor beta receptor-I expressing plasmid on pig serum-induced rat liver fibrosis. Zhonghua Yixue Zazhi 2002; 82: 1160-1164
32. 2+ exchanger emerges in hepatic stellate cells after activation in association with liver fibrosis. Physiology 1998; 95: 5389-5394
33. Ueno H, Sakamoto T, Nakamura T, Qi Z, Astuchi N, Takeshita A, Shimizu K, Ohashi H. A soluble transforming growth factor beta receptor expressed in muscle prevents liver fibrogenesis and dysfunction in rats. Hum Gene Ther 2000; 11: 33-42